Stocks
Allogene Therapeutics (ALLO) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -14.2 | -13.0 | -8.28 | -2.73 | -1.54 | -2.19 | ||
| Changes by years, y/y, % | +286% | -9% | -36% | -67% | -44% | -16.0% | |||
Allogene Therapeutics. P/E
Allogene Therapeutics. P/E, changes, %
Allogene Therapeutics (ALLO) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | -1.61 | -1.67 | -2.61 | -1.59 | -2.07 | -2.19 | |
| Changes by years, y/y, % | -68% | -39% | +27% | -23% | +29% | |||
| Changes by quarters, q/q, % | -23% | +4% | +56% | -39% | +30% | |||
